Simbec-Orion is a responsive and agile full-service CRO, with wide therapeutic experience and specialist expertise in clinical pharmacology, oncology and rare diseases. Perfectly structured, we provide full-service clinical development solutions for small and mid-size drug developers – headed up by a centralised leadership team.
With a focus on tailormade and scalable solutions, we’ll adapt our delivery style, communications and operations to suit the demands of your project, helping you achieve your clinical and commercial objectives. Because our goal is the same as yours; to improve patients’ lives.
With a focus on tailormade and scalable solutions, we’ll adapt our delivery style, communications and operations to suit the demands of your project, helping you achieve your clinical and commercial objectives. Because our goal is the same as yours; to improve patients’ lives.
Location: United Kingdom, Wales, Merthyr Tydfil
Employees: 201-500
Founded date: 1997
Mentions in press and media 4
| Date | Title | Description |
| 05.01.2022 | Embedding Neuroscience Techniques to Measure Target Engagement in First-In-Human CNS Clinical Trials, Upcoming Webinar Hosted by Xtalks | Using a variety of neuroscience tools and techniques at the Phase I or first-in-human (FIH) phase of the drug development pipeline, it is possible to gather the data and insights needed to build a detailed picture of the CNS effects of drug... |
| 08.11.2021 | Utilising a Virtual Central Laboratory Approach to Balance the Delivery, Budget and Risk for Clinical Trials, Upcoming Webinar Hosted by Xtalks | Ongoing challenges, such as Brexit, driver shortages, the Suez blockade and potential dry ice shortages have forced people to adopt a “new normal” to achieve their analytical results. TORONTO (PRWEB) November 08, 2021 Decentralization has b... |
| 04.06.2021 | Upcoming Panel Discussion, Hosted by Xtalks on Precision Oncology: An Era that Calls for a New Model for Conducting Clinical Trials? | Clinical trials have evolved from drug- to target-oriented trials, and this shift has raised several challenges. TORONTO, Ontario (PRWEB) June 04, 2021 Genomic sequencing techniques and bioinformatics have led us to a better understanding o... |
| 12.05.2021 | Accelerate Early Clinical Development with Adaptive, Multi-Part, First-in-Human Study Design | Upcoming Webinar Hosted by Xtalks | Proactively planning for additional study elements gives greater flexibility, allowing you to make decisions based on emerging data, without requiring additional regulatory approval. TORONTO (PRWEB) May 12, 2021 In early clinical developmen... |